Clinical Trials Logo

Clinical Trial Summary

The principal aim of this pilot study is to directly compare both approaches and analyze the failure rate after one year of follow-up. These data will serve as the basis to design a larger phase II or III trial in the future with failure rate as the primary end-point. Other study objectives are thoroughly described underneath.


Clinical Trial Description

Urethral stricture disease can occur throughout the entire length of the male urethra and has a wide variety of potential etiologies1. The standard treatment for this condition is urethroplasty, an open reconstructive procedure aiming to restore urethral patency1. Urethroplasty covers a wide variety of surgical techniques and can be performed in a single stage or in multiple stages1. The latter option is generally reserved for patients with a very challenging disease1 (often including very dense fibrosis and poor local tissue conditions) and is most commonly performed for urethral strictures in the penile urethra2. In case of a multi-stage urethroplasty, the first stage generally involves opening the urethra longitudinally over its diseased segment and suturing the urethral edges to the edges of the skin1. After that, a period of urethral rest of at least 3 months is foreseen after which the second stage procedure is performed by tubularizing the urethral plate around a transurethral catheter and closing the dartos layer and skin over the reconstructed urethra1. When the urethral plate is too narrow or of too poor quality to allow retubularization, the urethral plate is incised on the midline and a graft is sutured into the defect in order to augment the urethra enough to allow for retubularization after all1. This dorsal inlay procedure can be performed during the first or second stage1. To the best of our knowledge, there are no studies that directly compare the outcomes of both approaches and consequently, there is no clear guidance for surgeons as to whether the graft should be administered during the first or second stage of the procedure. Also, there are absolutely no data available to use in a power analysis for a randomized controlled trial investigating this matter. Against this background, the principal aim of this pilot study is to directly compare both approaches and analyze the failure rate after one year of follow-up. These data will serve as the basis to design a larger trial in the future with failure rate as the primary end-point. Other study objectives are thoroughly described underneath. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04965025
Study type Interventional
Source University Hospital, Ghent
Contact Nicolaas Lumen, MD, PhD
Phone +32 9 332 22 76
Email nicolaas.lumen@uzgent.be
Status Recruiting
Phase N/A
Start date November 11, 2020
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT03572348 - VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures. N/A
Completed NCT02321670 - Scandinavian Urethroplasty Study N/A
Recruiting NCT05519566 - The Accuracy of Pulsed Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram In Diagnosing Urethral Stricture N/A
Recruiting NCT04071925 - 9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
Terminated NCT02551783 - Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal Graft N/A
Active, not recruiting NCT03270384 - Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease N/A
Completed NCT03973619 - Urethral Stricture: A Comparison Between Jugal or Labial Graft Urethroplasty N/A
Withdrawn NCT03851952 - Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study N/A
Recruiting NCT04161365 - Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Urethral Strictures N/A
Completed NCT02948842 - Clostridium Histolyticum Collagenase Injection for Urethral Disease Phase 2
Not yet recruiting NCT03258658 - Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures Phase 1
Completed NCT03859024 - Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty Phase 4
Not yet recruiting NCT06064968 - Effectiveness of Intermittent Bladder Catheterization (IBC) in Reducing Recurrence of Urethral Stricture N/A
Active, not recruiting NCT03499964 - ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease N/A
Terminated NCT02634619 - A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty N/A
Not yet recruiting NCT00918528 - Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy Phase 1/Phase 2
Completed NCT05078788 - Holmium Laser Uretherotomy in Combination With Intralesional Steroids in Bulbar Uretheral Stricture N/A
Enrolling by invitation NCT03205670 - Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers Early Phase 1
Recruiting NCT05464290 - The Nanofat Regenerative Surgery for Management of Genital Lichen Sclerosus in Male and Female Patients N/A
Completed NCT04357080 - Factors Predicting Urethral Stricture Recurrence After Dorsal Onlay Augmented, Buccal Mucosal Graft Urethroplasty